The results of the studies presented showed that the thiomersal-free vaccines produced protective levels of antibodies against hepatitis B virus to a similar extent to the vaccines that contained thiomersal at the end of the vaccination course.
Resultaterne af de fremlagte undersøgelser viste, at de thiomersalfrie vacciner ved afslutningen af vaccinationsforløbet gav det samme niveau af antistoffer, der beskytter imod hepatitis B- virus, som de vacciner, der indeholdt thiomersal.